skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
FDA-approved medications that impair human spermatogenesis
Oncotarget, 2017-02, Vol.8 (6), p.10714-10725
Copyright: © 2017 Ding et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.12956 ;PMID: 27801671
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
FDA-approved medications that impair human spermatogenesis
Author:
Ding, Jiayi
;
Shang, Xuejun
;
Zhang, Zhanhu
;
Jing, Hua
;
Shao, Jun
;
Fei, Qianqian
;
Rayburn, Elizabeth R
;
Li, Haibo
Subjects:
Animals
;
Drug Approval
;
Drug Labeling
;
Fertility - drug effects
;
Humans
;
Infertility, Male - chemically induced
;
Infertility, Male - metabolism
;
Infertility, Male - pathology
;
Infertility, Male - physiopathology
;
Male
;
Review
;
Risk Assessment
;
Risk Factors
;
Spermatogenesis - drug effects
;
Spermatozoa - drug effects
;
Spermatozoa - metabolism
;
Spermatozoa - pathology
;
United States
;
United States Food and Drug Administration
Is Part Of:
Oncotarget, 2017-02, Vol.8 (6), p.10714-10725
Description:
We herein provide an overview of the single-ingredient U.S. Food and Drug Administration (FDA)-approved drugs that affect human spermatogenesis, potentially resulting in a negative impact on male fertility. To provide this information, we performed an in-depth search of DailyMed, the official website for FDA-approved drug labels. Not surprisingly, hormone-based agents were found to be the drugs most likely to affect human spermatogenesis. The next category of drugs most likely to have effects on spermatogenesis was the antineoplastic agents. Interestingly, the DailyMed labels indicated that several anti-inflammatory drugs affect spermatogenesis, which is not supported by the peer-reviewed literature. Overall, there were a total of 65 labels for drugs of various classes that showed that they have the potential to affect human sperm production and maturation. We identified several drugs indicated to be spermatotoxic in the drug labels that were not reported in the peer-reviewed literature. However, the details about the effects of these drugs on human spermatogenesis are largely lacking, the mechanisms are often unknown, and the clinical impact of many of the findings is currently unclear. Therefore, additional work is needed at both the basic research level and during clinical trials and post-marketing surveillance to fill the gaps in the current knowledge. The present findings will be of interest to physicians and pharmacists, researchers, and those involved in drug development and health care policy.
Publisher:
United States: Impact Journals LLC
Language:
English
Identifier:
ISSN: 1949-2553
EISSN: 1949-2553
DOI: 10.18632/oncotarget.12956
PMID: 27801671
Source:
GFMER Free Medical Journals
MEDLINE
PubMed Central
Alma/SFX Local Collection
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript